SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 110 filers reported holding SUTRO BIOPHARMA INC in Q3 2023. The put-call ratio across all filers is 1.10 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $57 | -72.9% | 12,250 | -73.1% | 0.00% | -80.0% |
| Q1 2023 | $210 | -99.9% | 45,540 | +105.2% | 0.01% | -16.7% |
| Q1 2022 | $182,000 | -59.6% | 22,189 | -26.7% | 0.01% | -78.6% |
| Q4 2021 | $450,000 | -30.2% | 30,262 | -11.4% | 0.06% | -34.9% |
| Q3 2021 | $645,000 | +53.9% | 34,152 | +51.5% | 0.09% | -39.0% |
| Q2 2021 | $419,000 | -59.8% | 22,550 | -50.8% | 0.14% | -57.7% |
| Q1 2021 | $1,042,000 | -25.3% | 45,790 | -28.7% | 0.33% | -16.3% |
| Q4 2020 | $1,395,000 | – | 64,250 | – | 0.40% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 1,675,579 | $13,773,000 | 3.47% |
| AJU IB Investment Co., Ltd. | 175,000 | $1,439,000 | 2.22% |
| Frazier Life Sciences Management, L.P. | 1,776,479 | $14,603,000 | 1.24% |
| First Light Asset Management, LLC | 1,672,497 | $13,748,000 | 1.21% |
| BVF INC/IL | 3,447,946 | $28,342,000 | 1.13% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,732,400 | $30,680,000 | 0.94% |
| Endurant Capital Management LP | 296,508 | $2,437,000 | 0.64% |
| Parkman Healthcare Partners LLC | 199,846 | $1,643,000 | 0.48% |
| Eventide Asset Management | 2,708,975 | $22,268,000 | 0.35% |
| Lombard Odier Asset Management (Switzerland) SA | 391,024 | $3,214,000 | 0.25% |